APA (7th ed.) Citation

Uchida, Y., Naiki, K., Kouyama, J., Sugawara, K., Nakao, M., Motoya, D., . . . Mochida, S. (2018). Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy. PloS one, 13(10), e0205600. https://doi.org/10.1371/journal.pone.0205600

Chicago Style (17th ed.) Citation

Uchida, Yoshihito, et al. "Serum Asunaprevir Concentrations Showing Correlation with the Extent of Liver Fibrosis as a Factor Inducing Liver Injuries in Patients with Genotype-1b Hepatitis C Virus Receiving Daclatasvir Plus Asunaprevir Therapy." PloS One 13, no. 10 (2018): e0205600. https://doi.org/10.1371/journal.pone.0205600.

MLA (9th ed.) Citation

Uchida, Yoshihito, et al. "Serum Asunaprevir Concentrations Showing Correlation with the Extent of Liver Fibrosis as a Factor Inducing Liver Injuries in Patients with Genotype-1b Hepatitis C Virus Receiving Daclatasvir Plus Asunaprevir Therapy." PloS One, vol. 13, no. 10, 2018, p. e0205600, https://doi.org/10.1371/journal.pone.0205600.